Literature DB >> 3558998

Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia.

H F Kauffman, B van der Belt, J G de Monchy, H Boelens, G H Koëter, K de Vries.   

Abstract

With the use of a percoll gradient separation procedure, eosinophils of individuals with asthma and with allergy could be separated into normal- and low-density cell fractions. The presence of low-density eosinophils possibly reflects an ongoing process of activation of these cells induced by the allergic reaction. Ca-ionophore-induced leukotriene (LT) C4 production, in the absence of added substrates, demonstrated a decreased potency for LT generation by low-density eosinophils compared with the LT generation of normal-density cells (57 +/- 33 ng and 103 +/- 44 ng per 10(6) cells, respectively). In contrast with the Ca-ionophore-induced LT formation, incubations with serum-treated zymosan in the presence of glutathione demonstrated higher productions of LTC4 with the low-density eosinophilic subpopulation compared with normal-density cells. This is compatible with a possibly higher expression of complement C3b receptors on the low-density eosinophils. Total arylsulfatase contents demonstrated that low-density eosinophils are not degranulated with respect to their small granules. Although release of the large granules by low-density eosinophils cannot be excluded, electron-microscopy studies indicated that degranulation is not the only (or major) factor that determines the density of the various eosinophilic subpopulations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558998     DOI: 10.1016/s0091-6749(87)80157-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

Review 1.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.

Authors:  T Yukawa; C Kroegel; P Evans; T Fukuda; K F Chung; P J Barnes
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

Review 3.  The pathogenesis of endomyocardial fibrosis: the role of the eosinophil.

Authors:  C J Spry
Journal:  Springer Semin Immunopathol       Date:  1989

4.  Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.

Authors:  M M Teixeira; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Morphology and density features of eosinophil leukocytes in eosinophilic pneumonia. A case report.

Authors:  C Kroegel; H Matthys; U Costabel
Journal:  Clin Investig       Date:  1992-05

6.  Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.

Authors:  M Miyasato; S Tsuda; M Kasada; K Iryo; Y Sasai
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Differential regulation of human eosinophil, macrophage, and neutrophil functions by the allergic mediator release inhibitor CI-959.

Authors:  C D Wright; L J Devall; K A Aker; D O Thueson; M C Conroy
Journal:  Agents Actions       Date:  1992-05

Review 8.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

9.  Allergen-induced airway responses in rats pretreated with Sephadex.

Authors:  P Rossi; L Xu; N S Wang; J G Martin
Journal:  Agents Actions       Date:  1993-11

10.  Production of platelet-activating factor by human normodense and hypodense eosinophils.

Authors:  A Ojima-Uchiyama; Y Masuzawa; T Sugiura; K Waku; T Fukuda; S Makino
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.